METHOD FOR INTEGRATED TREATMENT OF OBESITY ACCOMPANYING POLYCYSTIC OVARY SYNDROME Russian patent published in 2015 - IPC A61K31/365 A61K31/57 A61K36/21 A61P3/04 A61P5/30 

FIELD: medicine.

SUBSTANCE: integrated treatment of obesity accompanying polycystic ovary syndrome is ensured by using an integrated therapy involving verospiron 50 mg twice a day in the morning and in the evening from the 5^th to 25^th day of menstrual cycle, Dufaston 10 mg twice a day in the morning and in the evening from the 14^th to 25^th day of menstrual cycle according to the standard therapeutic schedule, Listata 120 mg three times a day with meals, biologically active supplement of hill-growing saltwort 0.25 g 2 tablets twice a day with meals for 3 months.

EFFECT: reducing body weight and correcting carbohydrate, lipid and hormone statuses with no side effects in the given category of patients.